Navigation Links
InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
Date:8/30/2007

BRISBANE, Calif., Aug. 30 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that Daniel G. Welch, President and Chief Executive Officer of InterMune, will present at the Thomas Weisel Healthcare Conference in Boston on September 5, 2007 at 3:50 p.m. EDT. Mr. Welch will also present at the Bear Stearns 20th Annual Healthcare Conference in New York City on September 11, 2007 at 3 p.m. EDT.

To access a live audio webcast of the presentations, investors and other interested parties may log on to the investor relations page of InterMune's corporate website at http://www.intermune.com. The company recommends logging on to the site 15 minutes prior to the start of the presentation in order to register or download any necessary software.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes the Phase 3 program, CAPACITY, which is evaluating pirfenidone as a possible therapeutic candidate for the treatment of patients with IPF and a research program focused on small molecules for pulmonary disease. The hepatology portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as R7227 within the Roche research and development programs) in Phase 1a, a second-generation HCV protease inhibitor research program, and a research program evaluating a new target in hepatology. For additional information about InterMune and its R&D pipeline, please visit

SOURCE InterMune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015 Natera, ... announced a study published in Ultrasound in ... single-nucleotide polymorphism (SNP)-based non-invasive prenatal test (NIPT) can ... trimester. A study based upon ... molar pregnancies occur in about 1 in 1,000 ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 BioNorth ... serving and representing the life sciences industry in ... of Directors meeting at The Foundry in Dallas ... the organization brought together a broad spectrum of ... underscored the organization's early successes in partnering with ...
(Date:5/28/2015)... Mass. , May 28, 2015 RXi ... focused on discovering and developing innovative therapeutics, primarily in ... pricing of a public offering of 26 million units ... share for gross proceeds of approximately $10.4 million. Each ... (ii) a 13-month overallotment purchase right to purchase 0.50 ...
(Date:5/28/2015)... 2015  GenVec, Inc. (Nasdaq: GNVC ) today ... Swirsky , will present a company overview at the ... on Thursday, June 4, 2015. The ... be available at the following link:  http://wsw.com/webcast/jeff88/gnvc .  ... To access, visit www.genvec.com , click on "Investors ...
Breaking Biology Technology:First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test 2First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test 3BioNorthTX Holds Inaugural Board of Directors Meeting 2BioNorthTX Holds Inaugural Board of Directors Meeting 3RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 3GenVec To Present At The Jefferies Healthcare Conference 2
... Wis. - Last Sunday morning, in the free-wheeling ... Huber shared secrets and strategies from her forthcoming book, ... which she expects to publish next year. , ,In ... professionals, Huber provided advice about maximizing efficiency and minimizing ...
... companies were nervously introducing their products to a sold-out ... and eager media. , ,DEMOfall 2006 was an amazing ... FutureScan panels were smart. The buzz in the pavilion ... , ,The DEMOgods smiled upon us as the 67 ...
... world's most worrisome health issues is one of the major ... Biotechnology and Medical Device Association . , ,The conference, which ... Institute in Waukesha, will not only feature addresses by ... but session topics on global biological threats and personalized medicine. ...
Cached Biology Technology:BarCamp talk turns to Internet dating 2BarCamp talk turns to Internet dating 3Basking (briefly) in the DEMOfall 2006 glow 2Wisconsin's role in health a focus of biotech event 2Wisconsin's role in health a focus of biotech event 3
(Date:5/21/2015)... 2015 The Sync Project™ , a ... health, today announced a collaborative partnership with Berklee,s ... center on collaboration on original research, joint course development ... the collaboration, The Sync Project and BerkleeICE are exploring ... in the 2015-2016 academic year.  The ...
(Date:5/20/2015)... May 20, 2015 NXT-ID, Inc. (NASDAQ: ... wholly owned subsidiary, 3D-ID LLC, a company engaged in ... for the biometrics technology portion of the recently awarded ... the Department of the Army. 3D-ID LLC ... for government, law enforcement and security agencies. ...
(Date:5/19/2015)... 2015  Technology is rapidly advancing, outpacing enterprises, ability ... cloud. Passwords and their management are soon to be ... specifications such as those developed by the FIDO Alliance™. ... presents for BYOD, COPE, IoT, and mobile payments, the ... In response to the call for ...
Breaking Biology News(10 mins):The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3
... WEST LAFAYETTE, Ind. - Chemical engineers at Purdue University ... and other biomass into biofuels, and they are proposing ... the Midwest to produce the fuels. "What,s ... available biomass -- wood chips, switch grass, corn ...
... MD, PhD, Professor and Head of Physiology at LSU Health ... grant over five years by the National Institute on Drug ... cannabinoids, the principal psychoactive component of marijuana, produce subtle changes ... HIV infection. As the grant,s principal investigator, Dr. ...
... us are simply overloaded with cholesterol, and now a report in ... be good news: There is more than one way to get ... heart disease. "Cholesterol really can,t be broken down," said Mark ... of it, it must be excreted, and now Brown and his ...
Cached Biology News:New biofuels processing method for mobile facilities 2New biofuels processing method for mobile facilities 3Cholesterol's other way out 2
Rabbit polyclonal antibody to NMDA NR2B [Tyr1336]...
... combines enterprise-scale sequence analysis software with the DeCypher ... With DeCypher, you can perform searches like these ... NCBI NT database in under 6 days ... DNA Use HMM analysis to compare ...
... MTT, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide), 50mg/vial. MTT is ... by living cells to yield a dark ... mitochondria, and even freshly dead cells do ... A is a component of Chemicons MTT ...
Mouse monoclonal antibody to FMN2 - formin 2...
Biology Products: